机译:P2Y12抑制剂单疗法与双抗血小板治疗植入冠状动脉洗脱支架患者的比较理由和设计(智能选择):一种潜在的多中心随机试验
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Department of Cardiovascular Medicine Regional Cardiocerebrovascular Center Wonkwang University;
Department of Cardiology Samsung Changwon Hospital Sungkyunkwan University School of Medicine;
Division of Cardiology Dongsuwon General Hospital;
Division of Cardiology Department of Internal Medicine Myongji Hospital;
Division of Cardiology Kangwon National University Hospital;
Division of Cardiology Department of Medicine Kangbuk Samsung Hospital Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
Division of Cardiology Department of Medicine Samsung Medical Center Sungkyunkwan University;
机译:P2Y12抑制剂单疗法与双抗血小板治疗植入冠状动脉洗脱支架患者的比较理由和设计(智能选择):一种潜在的多中心随机试验
机译:P2Y12抑制剂单药治疗对经皮冠状动脉介入的患者心血管事件的影响智能选择随机临床试验
机译:三重抗血小板治疗与双重抗血小板治疗减少长期冠状动脉病变药物洗脱支架植入后再狭窄的随机,双盲,多中心比较研究:DECLARE-LONG II(药物洗脱支架置入,西洛他唑治疗后减少晚期)的结果长期冠状动脉病变患者的再狭窄)试验。
机译:Apixaban与苯procoumon:口服抗凝加抗血小板治疗急性冠状动脉综合征和心房颤动的患者(方法-ACS-AF):理论和设计前瞻性随机平行开放标签盲 - 终点优势多中心试验对心房颤动患者的三重治疗与双重治疗和急性冠状动脉综合征接受冠状动脉抵抗
机译:DECLARE-LONG II药物洗脱支架植入后在长期冠状动脉病变中三联抗血小板疗法与双联抗血小板疗法减少再狭窄的随机,双盲,多中心比较(药物洗脱支架加西洛他唑治疗可减少晚期再狭窄。冠状动脉病变患者的临床试验)